Overview
Hiroki Akiba practices practicing medicine in Osaka, Japan.
His clinical expertise encompasses Hemolytic Disease of the Newborn, Tetanus, and Stomach Cancer.
He is actively involved in clinical research, co-authoring 36 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hiroki Akiba
Is Hiroki Akiba a top-rated expert for Hemolytic Disease of the Newborn?
MediFind is an objective health platform that identifies experts based on real-world data. Hiroki Akiba is classified as an Experienced expert for Hemolytic Disease of the Newborn, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hiroki Akiba participate in research or clinical trials?
Yes. Hiroki Akiba has published 36 articles and abstracts on conditions like Hemolytic Disease of the Newborn. You can view a list of Hiroki Akiba's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Hemolytic Disease of the NewbornMr. Akiba isExperienced. Learn about Hemolytic Disease of the Newborn.
- Stomach CancerMr. Akiba isExperienced. Learn about Stomach Cancer.
- TetanusMr. Akiba isExperienced. Learn about Tetanus.